Most Recent Articles by Brandon May
While the increase in cardiovascular risk factors is at least partially due to the obesity epidemic, the researchers believe the increase is multifactorial.
The investigators suggested that the models should be recalibrated based on geographic location for more individualized predictions.
A "ceiling" may exist for lamotrigine therapy above which remission from seizures may be unlikely.
The trial, sponsored by the University of Birmingham, is currently recruiting participants.
The findings suggest that changes in immune status may be a consequence of ALS.
More Articles by Brandon May
Neurology Advisor Articles
- Case Series: New Chronic Headache Subtype Uncovered
- Parkinsonism Diagnosis Linked to Cognitive Deficits
- Dose "Ceiling" May Exist for Epilepsy Treated With Lamotrigine
- ENCHANTED Update: No Role for Low-Dose Alteplase After All?
- Amyotrophic Lateral Sclerosis Progression Associated With Changes in Immune Status
- Migraine and Gastrointestinal Disorders: Elucidating an Association
- Alzheimer's Disease Risk Similar in Women and Men With APOE ε3/ε4 Genotype
- Multiple Sclerosis Risk Significantly Associated With Vitamin D Deficiency
- FDA Approves Device for Tx of Chronic Pain
- FDA Approves Demyelinating Polyneuropathy Treatment
- Neuropathic Pain Linked to Vitamin Deficiency in Rheumatoid Arthritis
- Prognostic Models for Predicting Death and Dependency in Parkinson's
- Physician Salaries are Stagnant
- Model Helps Identify Seizure Risk in Critically Ill
- Antiepileptic Drugs Linked to Impaired Bone and Muscle Development in Children